| GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain GH Dar, CC Mendes, WL Kuan, AA Speciale, M Conceição, A Görgens, ... Nature communications 12 (1), 6666, 2021 | 61 | 2021 |
| Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer R Kotcherlakota, DJ Srinivasan, S Mukherjee, MM Haroon, GH Dar, ... Journal of Materials Chemistry B 5 (34), 7082-7098, 2017 | 49 | 2017 |
| A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain MM Haroon, GH Dar, D Jeyalakshmi, U Venkatraman, K Saba, ... Journal of Controlled Release 228, 120-131, 2016 | 37 | 2016 |
| Efficiency of dual siRNA-mediated gene therapy for intervertebral disc degeneration (IVDD) RR Banala, SK Vemuri, GH Dar, V Palanisamy, M Penkulinti, MV Surekha, ... The Spine Journal 19 (5), 896-904, 2019 | 31 | 2019 |
| Systemic delivery of stable siRNA-encapsulating lipid vesicles: optimization, biodistribution and tumor suppression. MR Ghulam Hassan Dar, Vijaya Gopa Molecular Pharmaceutics 12, 610-20, 2015 | 22 | 2015 |
| Conformation-dependent binding and tumor-targeted delivery of siRNA by a designed TRBP2: Affibody fusion protein GH Dar, V Gopal, M Rao Nanomedicine: Nanotechnology, Biology and Medicine 11 (6), 1455-1466, 2015 | 20 | 2015 |
| Targeted liposomes to deliver DNA to cells expressing 5-HT receptors V Gopal, J Xavier, GH Dar, M Jafurulla, A Chattopadhyay, NM Rao International journal of pharmaceutics 419 (1-2), 347-354, 2011 | 20 | 2011 |
| Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease I Mumtaz, MO Ayaz, MS Khan, U Manzoor, MA Ganayee, AQ Bhat, ... Frontiers in Aging Neuroscience 14, 977411, 2022 | 8 | 2022 |
| Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease GH Dar, R Badierah, EG Nathan, MA Bhat, AH Dar, EM Redwan Frontiers in Aging Neuroscience 14, 967231, 2022 | 5 | 2022 |
| GAPDH controls extracellular vesicle biogenesis and enhances therapeutic potential of EVs in silencing the Huntingtin gene in mice via siRNA delivery GH Dar, CC Mendes, WL Kuan, M Conceição, S El-Andaloussi, I Mager, ... bioRxiv, 2020.01. 09.899880, 2020 | 5 | 2020 |
| Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain GH Dar, CC Mendes, WL Kuan, AA Speciale, M Conceição, A Görgens, ... Nature Communications 12, 2021 | 2 | 2021 |
| Ibtisam Mumtaz1, Mir Owais Ayaz2, 3, Mohamad Sultan Khan4, Umar Manzoor5, Mohd Azhardin Ganayee1, 6, Aadil Qadir Bhat2, 3, Ghulam Hassan Dar7, Badrah S. Alghamdi8, 9, Anwar M … I Mumtaz, MO Ayaz, MS Khan, U Manzoor, MA Ganayee, AQ Bhat, ... The alzheimer’s disease challenge, volume II 16648714, 161, 2023 | | 2023 |
| An extracellular vesicle GH Dar, M Wood, RA Baker, K Wei-Li US Patent App. 17/772,526, 2022 | | 2022 |
| Recombinant protein-based method for the delivery of silencer RNA to target the brain G Vijaya, GH Dar US Patent 10,640,539, 2020 | | 2020 |
| Targeted Delivery of Short Interfering RNA by Human TAR RNA-Binding Protein-Affibody Chimera GH Dar, E Nathan, NM Rao, V Gopal MOLECULAR THERAPY 21, S62-S62, 2013 | | 2013 |
Vijaya GopalCSIR-Centre for Cellular and Molecular Biology, Hyderabad在 ccmb.res.in 的电子邮件经过验证
